BEP Targeting Strategies in Ethiopia

Launched by HARVARD SCHOOL OF PUBLIC HEALTH (HSPH) · Nov 5, 2023

Keywords

ClinConnect Summary

This clinical trial, called "BEP Targeting Strategies in Ethiopia," is studying how to best provide special nutritional supplements to pregnant women in Addis Ababa, Ethiopia. These supplements contain balanced energy and protein, which are important for a healthy pregnancy. The researchers want to find out which methods of giving these supplements are most effective in preventing problems during pregnancy, such as low birth weight and stillbirth. They will also look at the costs of these different methods and how easy they are for women to use.

To be eligible for this trial, women must be between 18 and 49 years old, pregnant with a baby that is 24 weeks old or younger, and planning to stay in the study area for six weeks after giving birth. They also need to be able to attend regular health check-ups and not have allergies to peanuts or soybeans. If you join the trial, you will receive either the BEP supplements or follow a different strategy during your pregnancy, and researchers will track your health and your baby's health for six weeks after your baby is born. This study aims to help improve the outcomes for mothers and babies in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. pregnant women aged 18 to 49;
• • 2. attending antenatal visits in one of the study health facilities;
• • 3. with a gestational age of 24 weeks or less;
• • 4. no known allergies to peanuts or soybeans;
• • 5. having resided in the current location for at least 6 months;
• • 6. intending to continue antenatal follow-up in the health facility;
• • 7. intending to give birth and remain in the study area until six weeks after delivery; and
• • 8. willing to take the BEP supplements for the entire duration of the pregnancy if eligible.
• Exclusion Criteria:
• • Not meeting all of the inclusion criteria above